By using patented technology, the devices provide a cost-effective home care to reduce soft tissue pain and accelerate healing.

Under the agreement, ZEPHYRUS has gained rights to distribute the devices in the Balkan region, which include countries like Albania, Bosnia and Herzegnovina, Croatia, Kosovo, Macedonia, Montenegro, Serbia, and Slovenia.

BioElectronics marketing manager Ben Fichter said the company believes that the populations of these countries will embrace a safe, drug free, inexpensive product that provides more effective pain relief than any drug therapy.

"Our unique devices, patterned after larger devices that have been used safely and effectively for years in hospitals and physical therapy clinics, are five times better and 100 percent safer than over the counter drugs," Fichter added.

ZEPHYRUS director Jovan Radakovic said, "We are very proud of the quality of our service and excited about the opportunity to bring BIEL’s excellent products to a new marketplace."